Niagen Bioscience (NAGE) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Niagen Bioscience (NAGE) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.44 of bullish evidence against -0.40 bearish.

Niagen Bioscience last closed at $2.68, -3.94% on the session.

Against the IVW growth benchmark the position is -4.86% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

11 graded predictions for NAGE so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Niagen Bioscience in the 60th percentile on valuation and the 81st percentile on return on equity, where 100 is best.

Niagen Bioscience is classified under Consumer Staples / Personal Care Products, with a market capitalisation of $220.76M.

StockMap tracks Niagen Bioscience as the 13th largest of the 23 companies it covers in the Personal Care Products industry, part of the Consumer Staples sector.

Across that group the current two-week reads are 14 Moderate Underperform, 8 Neutral and 1 Strong Underperform.

On that composite Niagen Bioscience ranks 16th of 23 in the group, against a group median of -0.24.